| Title : Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment - Smith_2020_Alzheimers.Dement.(N.Y)_6_e12056 |
| Author(s) : Smith EE , Barber P , Field TS , Ganesh A , Hachinski V , Hogan DB , Lanctt KL , Lindsay MP , Sharma M , Swartz RH , Ismail Z , Gauthier S , Black SE |
| Ref : Alzheimers Dement (N Y) , 6 :e12056 , 2020 |
| Abstract : |
| PubMedSearch : Smith_2020_Alzheimers.Dement.(N.Y)_6_e12056 |
| PubMedID: 33209971 |
| Title : Predictors of Cholinesterase Discontinuation during the First Year after Nursing Home Admission - Maclagan_2018_J.Am.Med.Dir.Assoc_19_959 |
| Author(s) : Maclagan LC , Bronskill SE , Guan J , Campitelli MA , Herrmann N , Lapane KL , Hogan DB , Amuah JE , Seitz DP , Gill SS , Maxwell CJ |
| Ref : J Am Med Dir Assoc , 19 :959 , 2018 |
| Abstract : |
| PubMedSearch : Maclagan_2018_J.Am.Med.Dir.Assoc_19_959 |
| PubMedID: 30262440 |
| Title : Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease - Hogan_2014_Can.J.Psychiatry_59_618 |
| Author(s) : Hogan DB |
| Ref : Can J Psychiatry , 59 :618 , 2014 |
| Abstract : |
| PubMedSearch : Hogan_2014_Can.J.Psychiatry_59_618 |
| PubMedID: 25702360 |
| Title : Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012 - Herrmann_2013_Alzheimers.Res.Ther_5_S5 |
| Author(s) : Herrmann N , Lanctot KL , Hogan DB |
| Ref : Alzheimers Res Ther , 5 :S5 , 2013 |
| Abstract : |
| PubMedSearch : Herrmann_2013_Alzheimers.Res.Ther_5_S5 |
| PubMedID: 24565367 |
| Title : Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease - Amuah_2010_Pharmacoepidemiol.Drug.Saf_19_670 |
| Author(s) : Amuah JE , Hogan DB , Eliasziw M , Supina A , Beck P , Downey W , Maxwell CJ |
| Ref : Pharmacoepidemiol Drug Safety , 19 :670 , 2010 |
| Abstract : |
| PubMedSearch : Amuah_2010_Pharmacoepidemiol.Drug.Saf_19_670 |
| PubMedID: 20583207 |
| Title : Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia - Hogan_2008_CMAJ_179_1019 |
| Author(s) : Hogan DB , Bailey P , Black S , Carswell A , Chertkow H , Clarke B , Cohen C , Fisk JD , Forbes D , Man-Son-Hing M , Lanctot K , Morgan D , Thorpe L |
| Ref : Cmaj , 179 :1019 , 2008 |
| Abstract : |
| PubMedSearch : Hogan_2008_CMAJ_179_1019 |
| PubMedID: 18981443 |
| Title : Comparison studies of cholinesterase inhibitors for Alzheimer's disease - Hogan_2004_Lancet.Neurol_3_622 |
| Author(s) : Hogan DB , Goldlist B , Naglie G , Patterson C |
| Ref : Lancet Neurol , 3 :622 , 2004 |
| Abstract : |
| PubMedSearch : Hogan_2004_Lancet.Neurol_3_622 |
| PubMedID: 15380159 |
| Title : Progress in clincal neurosciences: Treatment of Alzheimer's disease and other dementias--review and comparison of the cholinesterase inhibitors - Hogan_2002_Can.J.Neurol.Sci_29_306 |
| Author(s) : Hogan DB , Patterson C |
| Ref : Can Journal of Neurology Sci , 29 :306 , 2002 |
| Abstract : |
| PubMedSearch : Hogan_2002_Can.J.Neurol.Sci_29_306 |
| PubMedID: 12463485 |
| Title : Brief review: rivastigmine, a second cholinesterase inhibitor - |
| Author(s) : Patterson C , Hogan DB |
| Ref : Can Journal of Neurology Sci , 28 Suppl 1 :S122 , 2001 |
| PubMedID: 11237306 |